Oxybutynin and tolterodine for treatment of neurogenic detrusor overactivity: a pharmacoeconomic evaluation in the Brazilian context. Brazilian Journal of Pharmaceutical Sciences, [S. l.], v. 48, n. 2, p. 227–236, 2012. DOI: 10.1590/S1984-82502012000200006. Disponível em: https://revistas.usp.br/bjps/article/view/46173.. Acesso em: 21 may. 2024.